UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma

Haematologica (Roma), 2016-09, Vol.101 (9), p.e387-e390

2016

Volltextzugriff (PDF)

Del(1p32): prime time in (ultra) high-risk myeloma

Blood, 2023-03, Vol.141 (11), p.1241-1243

Khot, Amit

2023

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Clinical cancer research, 2019-07, Vol.25 (13), p.3772-3775

2019

Volltextzugriff (PDF)

The role of 18F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co‐infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant

Transplant infectious disease, 2021-06, Vol.23 (3), p.e13547-n/a

2021

Volltextzugriff (PDF)

Impact of an allied health prehabilitation service for haematologic patients receiving high-dose chemotherapy in a large cancer centre

Supportive care in cancer, 2022-02, Vol.30 (2), p.1841-1852

2022

Volltextzugriff (PDF)

Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing

Haematologica (Roma), 2021-01, Vol.106 (1), p.313-315

2021

Volltextzugriff (PDF)

T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease

Bone marrow transplantation (Basingstoke), 2021-11, Vol.56 (11), p.2857-2859

2021

Volltextzugriff (PDF)

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling

Oncotarget, 2016-08, Vol.7 (31), p.49800-49818

2016

Volltextzugriff (PDF)

Where do we currently stand with T-cell prolymphocytic leukemia?

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.563-565

Khot, Amit

2019

Volltextzugriff (PDF)

Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.122-9, Article 122

2024

Volltextzugriff (PDF)

P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS

HemaSphere, 2023-08, Vol.7 (S3), p.e41693c0-n/a

2023

Volltextzugriff (PDF)

Myeloma and pregnancy: strange bedfellows?

Leukemia & lymphoma, 2014-04, Vol.55 (4), p.966-968

2014

Volltextzugriff (PDF)

Lenalidomide maintenance in Myeloma - a goldilocks problem?

Leukemia & lymphoma, 2023-10, Vol.64 (10), p.1611-1614

2023

Volltextzugriff (PDF)

Enablers and barriers to referral and delivery of multidisciplinary prehabilitation in the autologous stem cell transplant population: a theory-based interview study

Supportive care in cancer, 2024-01, Vol.32 (1), p.25-25, Article 25

2024

Volltextzugriff (PDF)

"RT or not RT?" The question for early-stage peripheral T-cell lymphoma

Leukemia & lymphoma, 2021-02, Vol.62 (3), p.511-513

2021

Volltextzugriff (PDF)

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

Cancer discovery, 2019-08, Vol.9 (8), p.1036-1049

2019

Volltextzugriff (PDF)

Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass index

Leukemia & lymphoma, 2023-01, Vol.64 (1), p.253-255

2023

Volltextzugriff (PDF)

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

Blood, 2015-01, Vol.125 (1), p.71-81

2015

Volltextzugriff (PDF)

A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results

British journal of haematology, 2018-01, Vol.180 (1), p.41-51

2018

Volltextzugriff (PDF)

Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

Molecular therapy, 2013-11, Vol.21 (11), p.2122-2129

2013

Volltextzugriff (PDF)

Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides

Bone marrow transplantation (Basingstoke), 2022-11, Vol.57 (11), p.1724-1726

2022

Volltextzugriff (PDF)

CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Blood, 2024-02, Vol.143 (8), p.673-684

2024

Volltextzugriff (PDF)

Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer

Clinical genitourinary cancer, 2024-12, Vol.22 (6), p.102234, Article 102234

2024

Volltextzugriff (PDF)

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

Leukemia & lymphoma, 2022-11, Vol.63 (13), p.3217-3221

2022

Volltextzugriff (PDF)

Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53 -mutated disease

Leukemia & lymphoma, 2023-11, Vol.64 (11), p.1792-1800

2023

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(99)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(50)
Humans
(33)
Hematology
(28)
Oncology
(25)
Male
(10)
Treatment Outcome
(10)
Female
(9)
Adult
(8)
Middle Aged
(8)
Aged
(7)
Hematopoietic Stem Cell Transplantation
(7)
Multiple Myeloma - Drug Therapy
(7)
Stem Cell Transplantation
(7)
Transplantation
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Cancer
(6)
Technology
(6)
Chemotherapy
(5)
Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma

Del(1p32): prime time in (ultra) high-risk myeloma

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

The role of 18F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co‐infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant

Impact of an allied health prehabilitation service for haematologic patients receiving high-dose chemotherapy in a large cancer centre

Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing

T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling

Where do we currently stand with T-cell prolymphocytic leukemia?

Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma

P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH CDK9 INHIBITOR AZD4573 IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL): EARLY TRIAL ANALYSIS

Myeloma and pregnancy: strange bedfellows?

Lenalidomide maintenance in Myeloma - a goldilocks problem?

Enablers and barriers to referral and delivery of multidisciplinary prehabilitation in the autologous stem cell transplant population: a theory-based interview study

"RT or not RT?" The question for early-stage peripheral T-cell lymphoma

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass index

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results

Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia

Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides

CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer

Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma

Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53 -mutated disease

Suchergebnisse filtern